Cargando…
Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
OBJECTIVE: Patients with compensated hepatitis B-related cirrhosis receiving antivirals are at the risk of hepatocellular carcinoma (HCC). This study aimed to develop and validate a nomogram for predicting the incidence of HCC in patients with hepatitis-B related cirrhosis. DESIGN: A total of 632 pa...
Autores principales: | Shi, Ke, Li, Ping, Zhang, Qun, Zhang, Yi, Bi, Yufei, Zeng, Xuanwei, Wang, Xianbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978349/ https://www.ncbi.nlm.nih.gov/pubmed/36874109 http://dx.doi.org/10.3389/fonc.2023.1128062 |
Ejemplares similares
-
Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis
por: Shi, Ke, et al.
Publicado: (2023) -
Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma
por: Shi, Ke, et al.
Publicado: (2023) -
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma
por: Shi, Ke, et al.
Publicado: (2023) -
Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis
por: Shi, Ke, et al.
Publicado: (2020) -
Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis
por: Gao, Fangyuan, et al.
Publicado: (2018)